Answers are grounded in this paper and cite their sources.
Everolimus therapy was associated with marked reduction in the volume of subependymal giant-cell astrocytomas and seizure frequency and may be a potential alternative to neurosurgical resection in some cases, though long-term studies are needed. (Funded by Novartis; ClinicalTrials.gov number, NCT00411619.).
No takes yet. Share an insight, caveat, or question.
Krueger et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: